King Dialysis Center Of Wake Forest University is a medicare approved dialysis facility center in King, North Carolina and it has 17 dialysis stations. It is located in Stokes county at 140 Moore Road, King, NC, 27021. You can reach out to the office of King Dialysis Center Of Wake Forest University at (336) 985-3531. This dialysis clinic is managed and/or owned by Wake Forest University. King Dialysis Center Of Wake Forest University has the following ownership type - Non-Profit. It was first certified by medicare in January, 2004. The medicare id for this facility is 342633 and it accepts patients under medicare ESRD program.
| Name | King Dialysis Center Of Wake Forest University |
|---|---|
| Location | 140 Moore Road, King, North Carolina |
| No. of Dialysis Stations | 17 |
| Medicare ID | 342633 |
| Managed By | Wake Forest University |
| Ownership Type | Non-Profit |
| Late Shifts | No |
| 140 Moore Road, King, North Carolina, 27021 | |
| (336) 985-3531 | |
News Archive
Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.
Olfactory health - how well we are able to smell - is a reliable marker of the health of the brain, but the "smell identification tests" commonly used in studies of olfactory health do not offer a complete picture of what is happening.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.
The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.
› Verified 3 days ago
| NPI Number | 1396722351 |
| Organization Name | King Dialysis Center |
| Doing Business As | King Dialysis Center Of Wake Forest University |
| Address | 140 Moore Rd King, North Carolina, 27021 |
| Phone Number | (336) 985-3531 |
News Archive
Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.
Olfactory health - how well we are able to smell - is a reliable marker of the health of the brain, but the "smell identification tests" commonly used in studies of olfactory health do not offer a complete picture of what is happening.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.
The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.
› Verified 3 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 69% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 14% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 17% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 74% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 17% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 9% | 14% |
News Archive
Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.
Olfactory health - how well we are able to smell - is a reliable marker of the health of the brain, but the "smell identification tests" commonly used in studies of olfactory health do not offer a complete picture of what is happening.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.
The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.
› Verified 3 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 74% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 17% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 9% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 85% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 15% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 0% | 12% |
News Archive
Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.
Olfactory health - how well we are able to smell - is a reliable marker of the health of the brain, but the "smell identification tests" commonly used in studies of olfactory health do not offer a complete picture of what is happening.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.
The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.
› Verified 3 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 85% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 15% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 88% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 12% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 0% | 12% |
News Archive
Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.
Olfactory health - how well we are able to smell - is a reliable marker of the health of the brain, but the "smell identification tests" commonly used in studies of olfactory health do not offer a complete picture of what is happening.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.
The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.
› Verified 3 days ago
| Dialysis patients with Hemoglobin data | 25 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 20 |
News Archive
Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.
Olfactory health - how well we are able to smell - is a reliable marker of the health of the brain, but the "smell identification tests" commonly used in studies of olfactory health do not offer a complete picture of what is happening.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.
The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.
› Verified 3 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 59 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 466 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.
Olfactory health - how well we are able to smell - is a reliable marker of the health of the brain, but the "smell identification tests" commonly used in studies of olfactory health do not offer a complete picture of what is happening.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.
The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.
› Verified 3 days ago
| Adult patients getting regular peritoneal dialysis at the center | 9 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 67 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.
Olfactory health - how well we are able to smell - is a reliable marker of the health of the brain, but the "smell identification tests" commonly used in studies of olfactory health do not offer a complete picture of what is happening.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.
The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.
› Verified 3 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at King Dialysis Center Of Wake Forest University with elevated calcium levels.
| Patients with hypercalcemia | 75 |
| Hypercalcemia patient months | 623 |
| Patients with Serumphosphor | 81 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 30 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 25 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 22 |
| Patients with Serumphosphor greater than 7 mg/dL | 13 |
News Archive
Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.
Olfactory health - how well we are able to smell - is a reliable marker of the health of the brain, but the "smell identification tests" commonly used in studies of olfactory health do not offer a complete picture of what is happening.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.
The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.
› Verified 3 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 36 |
| Patient months included in arterial venous fistula and catheter summaries | 265 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 61 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 28 |
News Archive
Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.
Olfactory health - how well we are able to smell - is a reliable marker of the health of the brain, but the "smell identification tests" commonly used in studies of olfactory health do not offer a complete picture of what is happening.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.
The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.
› Verified 3 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 60 |
| Hospitalization Rate in facility | 192.3 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 323.5 |
| Hospitalization Rate: Lower Confidence Limit | 118.6 |
News Archive
Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.
Olfactory health - how well we are able to smell - is a reliable marker of the health of the brain, but the "smell identification tests" commonly used in studies of olfactory health do not offer a complete picture of what is happening.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.
The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.
› Verified 3 days ago
The rate of readmission show you whether patients who were being treated regularly at King Dialysis Center Of Wake Forest University were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 18.1 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 28.1 |
| Readmission Rate: Lower Confidence Limit | 10.4 |
News Archive
Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.
Olfactory health - how well we are able to smell - is a reliable marker of the health of the brain, but the "smell identification tests" commonly used in studies of olfactory health do not offer a complete picture of what is happening.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.
The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.
› Verified 3 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at King Dialysis Center Of Wake Forest University get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.96 (As Expected) |
| SIR: Upper Confidence Limit | 3.6 |
| SIR: Lower Confidence Limit | .96 |
News Archive
Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.
Olfactory health - how well we are able to smell - is a reliable marker of the health of the brain, but the "smell identification tests" commonly used in studies of olfactory health do not offer a complete picture of what is happening.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.
The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.
› Verified 3 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether King Dialysis Center Of Wake Forest University's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 55 |
| Transfusion Rate in facility | 42.3 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 108.7 |
| Transfusion Rate: Lower Confidence Limit | 18.5 |
News Archive
Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.
Olfactory health - how well we are able to smell - is a reliable marker of the health of the brain, but the "smell identification tests" commonly used in studies of olfactory health do not offer a complete picture of what is happening.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.
The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.
› Verified 3 days ago
The rate of mortality show you whether patients who were being treated regularly at King Dialysis Center Of Wake Forest University lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 263 |
| Mortality Rate in facility | 18.8 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 24.7 |
| Mortality Rate: Lower Confidence Limit | 14 |
News Archive
Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.
Olfactory health - how well we are able to smell - is a reliable marker of the health of the brain, but the "smell identification tests" commonly used in studies of olfactory health do not offer a complete picture of what is happening.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.
The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.
› Verified 3 days ago
King Dialysis Center Of Wake Forest University Location: 140 Moore Road, King, North Carolina, 27021 Phone: (336) 985-3531 |
News Archive
Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.
Olfactory health - how well we are able to smell - is a reliable marker of the health of the brain, but the "smell identification tests" commonly used in studies of olfactory health do not offer a complete picture of what is happening.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.
The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.
› Verified 3 days ago